Speakers: Marta Papini, Tom Ransohoff, Stewart McNaull
The need for advanced technology platforms that offer a clear, end-to-end path to commercial manufacturing is driving biotech companies to outsource critical stages of their biomanufacturing process.
In this informative webinar, biotech leaders provide thought-provoking examples of applying a stage-gate approach throughout the drug development lifecycle. The information presented will highlight how to perform critical activities leveraging process and analytical development resources from early-stage clinical to commercialization.
Key learning objectives:
- How to adopt a stage-gate approach to biomanufacturing development that is highly flexible yet ensures that critical activities for each stage are effectively delivered
- Gain insight into creating a suitable tech transfer process for both early and late-stage programs
- Deep dive into process and analytical development capabilities that support effective development
